Stock listing

Enanta Pharmaceuticals, Inc.

Selected listing: A1T7BJ · LSX · EUR · DE

Enanta Pharmaceuticals, Inc. (LS Exchange: A1T7BJ), Health Technology. Latest release Aug 10, 2026: Enanta Pharmaceuticals Reports Financial Results…

A1T7BJ:LSXEURDEUpdated October 2, 2026
Enanta Pharmaceuticals, Inc. logo
Ticker
LS Exchange: A1T7BJ
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LS Exchange
Currency
EUR

About Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc. (Ticker: ENTA) is a public company based in the United States, focusing on the development of innovative therapies for viral infections and liver diseases. The company is actively engaged in research and development to bring new treatments to market.

Latest news from Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026

August 10, 2026

Entera Announces Second Quarter 2026 Financial Results and Business Updates

August 7, 2026

Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus

June 23, 2026

Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus

June 19, 2026

Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV)

June 18, 2026

All Enanta Pharmaceuticals, Inc. news →

Events

Replays

  • Enanta Pharmaceuticals, Inc. (ENTA) Q2 2024 Earnings Call

    Mon, May 06, 2024 · 04:30 PM ET

    Watch

  • Enanta Pharmaceuticals, Inc. (ENTA) Q1 2024 Earnings Call

    Wed, Feb 07, 2024 · 04:30 PM ET

    Watch

  • Enanta Pharmaceuticals, Inc. (ENTA) Q4 2023 Earnings Call

    Mon, Nov 20, 2023 · 04:30 PM ET

    Watch

Research Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc. company profile

View the public company page for Enanta Pharmaceuticals, Inc. on 6ix.

Enanta Pharmaceuticals, Inc. news

Read company news and market updates connected to Enanta Pharmaceuticals, Inc..

Enanta Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Enanta Pharmaceuticals, Inc..

Alternate listings

ENTA:NASDAQ

US · USD

Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LSX.

9EP:GETTEX

DE · EUR

Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LSX.

A1T7BJ:LS

DE · EUR

Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LSX.

9EP:TRADEGATE

DE · EUR

Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LSX.

ENTA:BOATS

US · USD

Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LSX.

9EP:MUN

DE · EUR

Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LSX.

9EP:BX

CH · CHF

Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LSX.

9EP:DUS

DE · EUR

Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LSX.

9EP:FWB

DE · EUR

Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LSX.

9EP:SWB

DE · EUR

Alternate listing for Enanta Pharmaceuticals, Inc.; the primary context on this page is A1T7BJ:LSX.